In one paragraphArticle in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Carmela De MarcoMolecular Oncology Laboratory, Department of Experimental and Clinical Medicine, "Magna Graecia" University, 88100 Catanzaro, Italy.ORCID 0000-0002-4893-4246 Valentina RoccaMolecular Oncology Laboratory, Department of Experimental and Clinical Medicine, "Magna Graecia" University, 88100 Catanzaro, Italy.ORCID 0000-0002-8331-5723 Simona MigliozziClinical Genomics and Therapeutics Division, Translational Genomics Research Institute (TGen), Phoenix, AZ 85004, USA.ORCID 0000-0002-4870-8943 Claudia VenezianoMolecular Oncology Laboratory, Department of Experimental and Clinical Medicine, "Magna Graecia" University, 88100 Catanzaro, Italy.
Francesca GualtieriMolecular Oncology Laboratory, Department of Experimental and Clinical Medicine, "Magna Graecia" University, 88100 Catanzaro, Italy.
Annamaria CerantonioMolecular Oncology Laboratory, Department of Experimental and Clinical Medicine, "Magna Graecia" University, 88100 Catanzaro, Italy.
Tahreem Arshad ButtMolecular Oncology Laboratory, Department of Experimental and Clinical Medicine, "Magna Graecia" University, 88100 Catanzaro, Italy.
Gianluca SantamariaMolecular Oncology Laboratory, Department of Experimental and Clinical Medicine, "Magna Graecia" University, 88100 Catanzaro, Italy.ORCID 0000-0001-9284-7492 Maria Teresa De AngelisMolecular Oncology Laboratory, Department of Experimental and Clinical Medicine, "Magna Graecia" University, 88100 Catanzaro, Italy.ORCID 0000-0003-3926-0611 Annalisa Di CelloUnit of Obstetrics and Gynecology, Department of Experimental and Clinical Medicine, "Magna Graecia" University, 88100 Catanzaro, Italy.ORCID 0000-0002-2454-1413 Roberta VenturellaUnit of Obstetrics and Gynecology, Department of Experimental and Clinical Medicine, "Magna Graecia" University, 88100 Catanzaro, Italy.
Fulvio ZulloUnit of Obstetrics and Gynecology, Department of Experimental and Clinical Medicine, "Magna Graecia" University, 88100 Catanzaro, Italy.ORCID 0000-0003-3726-7561 Giuseppe VigliettoMolecular Oncology Laboratory, Department of Experimental and Clinical Medicine, "Magna Graecia" University, 88100 Catanzaro, Italy.ORCID 0000-0003-2327-7515 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
DNA repairepigenetic modificationhigh-grade serous ovarian carcinomanext-generation sequencingoncogenic signalingplatinum resistanceprognostic biomarkerstranscriptional regulation
Identifiers
PMID42122186
PMCPMC13163086
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390